Literature DB >> 7429292

Ursodeoxycholic acid therapy and biliary lipids--a dose-response study.

M C Bateson, P E Ross, J Murison, J H Saunders, I A Bouchier.   

Abstract

The effects of four different doses of ursodeoxycholic acid (250, 500, 750, and 1000 mg daily) on biliary lipids were studied in 24 patients with radiolucent gallbladder stones. There was a significant increase in the proportion of ursodeoxycholic acid in bile after all doses, being greatest with 750 and 1000 mg daily. Unsulphated lithocholic acid was also increased in the bile after therapy, while the other major bile acids were reduced. The cholesterol content of bile was reduced by all doses, and this change was most marked after 1000 mg (from 10.9 +/- 1.4 to 5.6 +/- 0.5 mol%, P < 0.01). Biliary cholesterol saturation improved significantly only after 750 and 1000 mg daily.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7429292      PMCID: PMC1419617          DOI: 10.1136/gut.21.4.305

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  27 in total

1.  The estimation of phospholipids in bile.

Authors:  J Murison; D Festi; P E Ross; I A Bouchier
Journal:  Clin Chim Acta       Date:  1976-04-15       Impact factor: 3.786

2.  Effect of dietary chenodeoxycholic acid and lithocholic acid in the rabbit.

Authors:  C D Fischer; N S Cooper; M A Rothschild; E H Mosbach
Journal:  Am J Dig Dis       Date:  1974-10

3.  Letter: A simple calculation of the lithogenic index of bile: expressing biliary lipid composition on rectangular coordinates.

Authors:  P J Thomas; A F Hofmann
Journal:  Gastroenterology       Date:  1973-10       Impact factor: 22.682

4.  The solubility of cholesterol in aqueous solutions of bile salts and lecithin.

Authors:  F G Hegardt; H Dam
Journal:  Z Ernahrungswiss       Date:  1971-04

5.  Lithogenic bile among young Indian women.

Authors:  J L Thistle; L J Schoenfield
Journal:  N Engl J Med       Date:  1971-01-28       Impact factor: 91.245

6.  The metabolism of bile acids with special reference to liver injury.

Authors:  J B Carey; I D Wilson; F G Zaki; R F Hanson
Journal:  Medicine (Baltimore)       Date:  1966-11       Impact factor: 1.889

7.  Chenodeoxycholic acid treatment of gallstones. A follow-up report and analysis of factors influencing response to therapy.

Authors:  J H Iser; H Dowling; H Y Mok; G D Bell
Journal:  N Engl J Med       Date:  1975-08-21       Impact factor: 91.245

8.  Lithogenic bile.

Authors:  M Jimi; S Nagamitsu
Journal:  Gastroenterol Jpn       Date:  1976

9.  Cholesterol solubility in bile. Evidence that supersaturated bile is frequent in healthy man.

Authors:  R T Holzbach; M Marsh; M Olszewski; K Holan
Journal:  J Clin Invest       Date:  1973-06       Impact factor: 14.808

10.  The physicochemical basis of cholesterol gallstone formation in man.

Authors:  W H Admirand; D M Small
Journal:  J Clin Invest       Date:  1968-05       Impact factor: 14.808

View more
  8 in total

1.  Geographical variations in disease in Britain.

Authors:  M C Bateson
Journal:  Br Med J (Clin Res Ed)       Date:  1981-09-05

2.  Management of stones in the biliary tree.

Authors:  R H Dowling
Journal:  Gut       Date:  1983-07       Impact factor: 23.059

Review 3.  Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. Part II.

Authors:  W H Bachrach; A F Hofmann
Journal:  Dig Dis Sci       Date:  1982-09       Impact factor: 3.199

Review 4.  Ursodeoxycholic acid: a review of its pharmacological properties and therapeutic efficacy.

Authors:  A Ward; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-02       Impact factor: 9.546

5.  Ursocholic acid: bile acid and bile lipid dose response and clinical studies in patients with gall stones.

Authors:  P J Howard; D Gleeson; G M Murphy; R H Dowling
Journal:  Gut       Date:  1989-01       Impact factor: 23.059

Review 6.  Chenodeoxycholic acid: a review of its pharmacological properties and therapeutic use.

Authors:  J H Iser; A Sali
Journal:  Drugs       Date:  1981-02       Impact factor: 9.546

7.  Ursodeoxycholic acid therapy for primary biliary cirrhosis. A 10-year British single-centre population-based audit of efficacy and survival.

Authors:  M C Bateson; P Gedling
Journal:  Postgrad Med J       Date:  1998-08       Impact factor: 2.401

8.  Differing effects of ursodeoxycholic or chenodeoxycholic acid on biliary cholesterol saturation and bile acid metabolism in man. A dose-response study.

Authors:  J L Thistle; N F Larusso; A F Hofmann; J Turcotte; G L Carlson; B J Ott
Journal:  Dig Dis Sci       Date:  1982-02       Impact factor: 3.199

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.